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Exon array analysis <p>An annotation database (X:MAP) and BioConductor/R package (exonmap) have been developed to support fine-grained analysis of  exon array data.</p>
Abstract
Affymetrix exon arrays contain probesets intended to target every known and predicted exon in
the entire genome, posing significant challenges for high-throughput genome-wide data analysis.
X:MAP http://xmap.picr.man.ac.uk, an annotation database, and exonmap http://
www.bioconductor.org/packages/2.0/bioc/html/exonmap.html, a BioConductor/R package, are
designed to support fine-grained analysis of exon array data. The system supports the application
of standard statistical techniques, prior to the use of genome scale annotation to provide gene-,
transcript- and exon-level summaries and visualization tools.
Rationale
Alternative splicing has been implicated in a wide range of
human diseases, including neuropathological conditions
such as Alzheimer's disease, cystic fibrosis, those involving
growth and developmental defects, and many human cancers
[1,2]. It is involved in diverse cellular processes, including
apoptosis, invasion, angiogenesis and differentiation [1], and
can impact on both the efficacy and the toxicology of drugs
[3].
Given that 40% to 60% of all human genes, corresponding to
approximately 70% of all multi-exon genes, are predicted to
be alternatively spliced [4,5], the prospect of being able to
investigate coordinated changes i n  g e n e  e x p r e s s i o n  a t  t h e
level of individual isoforms is of significant interest. Recently,
a new generation of microarrays has been designed with sub-
stantially higher probe densities than were previously availa-
ble, allowing probes to be targeted at individual exons and
gene expression to be monitored at much finer granularities
than before. The Affymetrix Exon 1.0 ST array, for example,
has approximately 5.5 million features, corresponding to
approximately 1.4 million probesets, targeting approximately
1.2 million individual exons. The aim was to design an array
that interrogated every single known and predicted exon in
the human genome.
While such arrays offer great promise, they also pose major
challenges for data analysis. Figure 1, for example, shows the
transcript and exon structure for the 5' end of the oestrogen
receptor (ESR1) gene accompanied by Affymetrix probeset
target locations. The gene is represented by probesets target-
ing known exons, introns, putative exons, the untranslated
regions (UTRs) and genomic sequences, both up- and down-
stream of the predicted gene. This level of coverage poses two
problems: first, it must be possible to present and interpret
such data for each individual gene of interest. Second, if anal-
ysis is to be pursued systematically (rather than simply by
selecting genes based on prior knowledge), techniques for
global, high-throughput, analyses of the entire expression
dataset must also be available.
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Gene annotation is a graph
These challenges are compounded by the underlying com-
plexity inherent in gene expression. In particular, the many-
many relationships between genes, transcripts and exons
define a graph structure that cannot be adequately repre-
sented as a table, and this is made more complex by the fact
that a small but significant proportion of probes on the exon
arrays (approximately 5%) are capable of hybridizing to mul-
tiple locations within the expressed genome [6]. This trans-
lates to >9% of probesets on the array.
Affymetrix microarrays use multiple probes targeting a par-
ticular region of interest, which are grouped in software to
form a 'probeset'. In the initial stages of data processing, the
signal from each probeset's constituent probes is combined in
order to provide a summary value for that probeset. A variety
of algorithms exist to do this, but all offer some kind of
weighted or trimmed average, often moderated by an esti-
mate of background signal. While Affymetrix offer their own
probeset definitions, a number of alternative annotation
strategies have been developed (see [7], for example).
Although there is some variation in implementation, the
overall approach is common: to map probe locations to a
database of annotation, and to use this information to define
new probesets based on gene, transcript or exon structure.
Once these new probesets have been defined, they can be used
X:MAP displaying the 5' end of ESR1 Figure 1
X:MAP displaying the 5' end of ESR1. The web interface can be searched by gene symbol, Ensembl ID, location or probeset ID. The central portion of the 
viewer is interactive and can be scrolled in real time by dragging with the mouse. Orange filled bars represent exons. UTRs are indicated by the white-filled 
portions of the exons. The tree in the bottom left panel displays, for the gene of interest, a hierarchy showing the relationship between genes, transcripts, 
exons, probesets, probes and their genome hit. Specificity of the probe-genome match is also displayed. The bottom right panel is context sensitive and is 
used to present detailed information for the selected item in the tree. These include hyperlinks to external annotation resources.http://genomebiology.com/2007/8/5/R79 Genome Biology 2007,     Volume 8, Issue 5, Article R79       Okoniewski et al. R79.3
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to provide summary expression data. For example, a gene-
centric probeset definition file might be generated in which a
single monolithic probeset is created for each gene. Although
this loses information at the level of individual exons, it offers
the opportunity of providing gene-level data similar to those
presented by 'traditional' expression arrays.
One issue that arises with such an approach is that in the
design of their arrays, Affymetrix have included probesets
that target exons predicted with different levels of confidence.
Monolithic gene/transcript probesets must, therefore, either
include low-confidence probes, with the potential to incorpo-
rate a significant number of false positives, or reject them,
potentially missing putative coding regions and novel or pre-
viously uncharacterized genes or exons. In addition, not all
transcribed RNA forms part of the coding sequence of a pro-
tein, and genes can overlap or contain one another. There are
many non-coding genes, including rRNAs, tRNAs, small
nucleolar RNAs (snoRNAs) and microRNAs, substantial anti-
sense transcription, and even the possibility of low-level
'leaky transcription' [8-10]. At the time of writing a total of
31,718 genes are represented in the Ensembl human data-
base, of which 11,241 (35%) have more than one annotated
transcript. This is smaller than the 40% to 60% estimated in
[4,5], and suggests that there are likely to be many alternative
splicing events without representation in the databases.
Probeset annotation strategies based solely on current data-
base content are likely to miss many of these. A significant
amount of care must, therefore, be taken when grouping
probes together on the basis of their proximity to a known
gene.
Post-summary analysis of exon array data
Rather than using annotated gene structure to define large
probesets (that is, prior to expression summary), an alterna-
tive approach is to make use of the original small (4-probe)
probesets defined by the manufacturer, and only apply addi-
tional annotation data after the expression summary step.
One advantage of this is that both high- and low-confidence
probesets can be included in the initial analysis, since they
can later be excluded if necessary on the basis of, for example,
their actual expression levels in real data. Maintaining the
standard probeset definitions also makes it easier to compare
between different experiments, both at the annotation level
(as discussed in the MIAME recommendations [11]), and at
the level of raw data. This is particularly important since dif-
ferences in probeset mappings have been cited as a contribu-
tory factor to the poor correspondence often reported
between microarray experiments [6,12,13]. Recently, it has
also been shown that high levels of reproducibility can be
found between Exon 1.0 ST arrays and the previous genera-
tion of HGU133plus2 chips, when attention is paid to the
location of the individual probesets forming the mappings
between arrays [6].
Thus, the approach described here utilizes a strategy in which
probe sequences were mapped by in silico search to the entire
genome, and associated with an annotation database. Exist-
ing probeset definitions are used, and detailed annotation
only employed following expression summary. In the next
two sections, the software is described, followed by an exem-
plar study.
X:MAP, a database of fine-grained annotation 
for Affymetrix exon arrays
X:MAP is an annotation database built by mapping Affyme-
trix probeset sequences to the entire human genome, using a
hashing approach similar to that described in [14,15]. These
data are stored in a relational database implemented using
mySQL, and associated with a local copy of the Ensembl data-
base [16]. Probeset mapping code is implemented in Java,
while database population is coordinated by a series of scripts
that manage data download, probeset definition file parsing
and database updates. For Ensembl build Homo Sapiens core
40 36 b, the software identifies 23,555,980 genome hits, from
5,467,261 probes that together form 1,432,150 probesets. On
a dual processor 64 bit Linux workstation the entire process,
including database updates, takes about 3 hours and gener-
ates about 1.2 GB of mapping data. In order to support local,
or site-wide, installations, SQL data are available for down-
load. In total, a local installation to support human arrays is
approximately 16 Gb, including both Ensembl, and the addi-
tional mapping tables and indexes. Although large, this is
comparable in size to the amount of raw data generated by a
single exon array project, where each sample generates
approximately 1.1 Gb of data (including DAT files), and is still
of a reasonable size that can be accommodated by a modern
workstation.
The X:MAP genome browser
A challenge with genome browsing software is to provide an
interface that responds fast enough to allow efficient interac-
tion and browsing (Figure 1). The X:MAP interface makes use
of the Google maps API [17] to provide a fully interactive, real
time scrollable representation. The web interface is provided
via tomcat and also allows the database to be searched
according to gene name/symbol, transcript- or exon-id, and
by genomic location. A hierarchical view of the gene-tran-
script-exon-probeset relationship is provided, along with
hyperlinks to a variety of external annotation resources. A
publicly accessible installation is available at [18].
exonmap, a BioConductor/R package for Exon 
array analysis
An associated client-side BioConductor/R [19] package can
connect to the database and execute a series of queries that
allow associations between probesets, exons, genes and tran-
scripts to be identified. Since many of these queries involveR79.4 Genome Biology 2007,     Volume 8, Issue 5, Article R79       Okoniewski et al. http://genomebiology.com/2007/8/5/R79
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combining data extracted from multiple tables within the
database, they are implemented as stored procedures on the
database server. This results in much smaller data-transfer
overheads between server and client, lower client-side mem-
ory requirements and makes use of the database infrastruc-
ture, which is specifically optimized for these tasks. It was the
requirement for tightly coupled low-level access to both fine-
grained (that is, exon level) genome annotation and probeset
location data that led to the development of a single inte-
grated database rather than building a database containing
only probe and probeset hits, and making use of another
external annotation resource such as EnsMart [20], BioMart
[21] or ElDorado [22].
To the user, exonmap presents a set of functions of the form
X.to.Y()  (for example, probeset.to.gene()) that allow cross
mappings to be made freely between probesets, exons, tran-
scripts and genes. In addition, filtering functions are provided
to include or exclude probesets based on the features they hit,
and a variety of visualization functions to map and plot
probeset expression levels as a function of gene-structure.
These operations are described in more detail in the example
below. Together they allow different features of the data to be
explored, such as those characterized in Table 1, or to be
mapped onto individual genes, and related to probeset
expression, as in the gene plots.
Overview of operation
An analysis pipeline such as that shown in Figure 2 may be
used. Steps 1, 2 and 3 (expression summary, normalization,
and identification of differentially expressed probesets) are
identical to those that might be employed for standard
expression arrays. Since the focus of this article is on annota-
tion, we do not focus on the different strategies available for
generating initial expression summaries, or for using these to
identify a list of differentially expressed probesets (that is,
steps 1, 2 and 3). It is our experience that current techniques
work well, although particular care must be taken with multi-
ple testing correction, given the large number of probesets
represented on an exon array and their non-independence.
Once an appropriate probeset list has been generated, data-
base queries are used to map probesets to genome structure.
R functions exist to provide bi-directional mappings between
probesets, genes, transcripts and exons. These can be used to
identify genes where at least one probeset is differentially
expressed (step 4), and then to provide full data for each of
these genes (step 5). The software allows journal quality car-
toons to be generated depicting the genomic structure of the
region of interest and colored according to, for example, fold-
change or expression level (Figures 3 and 4); alternatively,
functions are provided to invoke an instance of a web browser
targeted at the X:MAP query page and centered on the gene of
interest (Figure 1).
An example
Two cell lines were compared in triplicate, the human breast
cancer cell line MCF7, and the non-tumorigenic breast epi-
thelial cell line, MCF10A, which, unlike MCF7, lacks tumori-
genicity in nude mice, three-dimensional growth in collagen,
and spontaneous- and anchorage-independent growth. Full
protocols are available in Additional data file 1, and data may
be downloaded from [23].
In the following analysis, differentially expressed probesets
were identified using SAM [24], as implemented in the
siggenes package in BioConductor. We use SAM here because
it is a popular and well understood method that provides a
starting point from which to explore the database. Other
approaches can clearly be substituted, but a discussion of
their relative merits for exon array data is outside the scope of
this article. It should be noted in passing, however, that the
large number of non-independent probesets that are found
within exon array data (since many genes are targeted by
multiple probesets) pose significant challenges for algorithms
that estimate false discovery rates (FDRs), or that correct for
multiple testing. The infrastructure described here provides a
possible source of annotation data with which to better
inform these algorithms.
Table 1
Number of features identified
List Total no.
1 DE probesets* 11,109
2 Unique genes 1,507
3 Exons with ≥1 DE probeset 7,589
4 Genes from list 2 with CV of their exons >0.5 835
5 Novel expressed regions 2,125
6 Novel expressed regions outside known genes 1,170
7 Novel expressed regions within known genes 955
8 Genes with putative exons 382http://genomebiology.com/2007/8/5/R79 Genome Biology 2007,     Volume 8, Issue 5, Article R79       Okoniewski et al. R79.5
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Raw expression data were processed in R using the affy Bio-
Conductor libraries. Expression summarization was per-
formed using RMA [25,26] with chip definitions supplied via
a custom CDF file that included all probesets originally
defined by Affymetrix, but with background and control
probesets removed. These can also be downloaded from the
X:MAP website.
Identifying differentially expressed known genes
The X:MAP database was then used via the exonmap R pack-
age to map these probesets to exons and to the genes that con-
tain them. This mapping is achieved using an R function that
calls a stored procedure on the database server. Implementa-
tion details are hidden from the user; the API simply provides
a set of functions of the form X.to.Y(<ID:String[]>) that han-
dle the intricacies of database IO and connections internally.
For example, the function probeset.to.gene(probestid) takes
a list of probeset IDs and returns a corresponding gene list,
and was used to generate a list representing genes for which
one or more probesets is differentially expressed. With a FDR
of 8.1%, 11,109 probesets (these data are subsequently
referred to as list 1) were identified in this way. Other options
include mapping to introns (that is, include matches to
regions not identified as containing an Ensembl exon, but
within the extent of a known gene), transcripts, and to inter-
genic regions (discussed below). By choosing to include/
exclude intron and intergenic matches, an explicit decision
can be made as to whether to focus on well characterized
regions. It is also important to apply a filtering to remove
probesets containing probes capable of hybridizing in multi-
ple locations; functions are included to filter probesets based
on their specificity. When only matches between 'well
behaved' probesets and known genes or exons are considered,
the 11,109 Differentially Expressed (DE) probesets identified
above map to 1,507 unique genes (henceforth, list 2) and
7,589 unique exons (list 3). All data are summarized in Table
1. By treating list 2 as a list of putative genes in which at least
one exon is changing in 'expression' between replicate groups,
it is possible to pursue them in more detail.
A number of strategies exist for doing this [27]. Here we use a
variation of the 'splicing index' described in [28] to prioritize
genes according to effects size. Other approaches, such as
splicing ANOVA (MIDAS) [27] and ANOSVA [29], can be
used similarly to select or prioritize based on statistical
significance.
Use of the exonmap infrastructure to analyse exon microrrays Figure 2
Use of the exonmap infrastructure to analyse exon microrrays. A processing pipelines using exonmap and X:MAP software. The first steps (1-3) are similar 
to standard microarray analysis. Step 4 is specific for exonmap, and is a combination of filtering and mapping between genes, transcripts, exon and 
probesets using genomic annotations from X:MAP. Step 5 comprises gene visualizations (see Figures 3 and 4).
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While most exons are targeted by a single probeset (68.5%), a
substantial proportion are targeted by more than one (Figure
5). Each of the probesets in list 2 was mapped to its target
exons, and for each exon, all probesets targeting that exon
retrieved. All genes from list 2 were found in which at least
one probeset showed greater than two-fold differential
expression. For these, the median fold change for each exon
was calculated. A series of gene-wise summaries were then
produced (list 4), including exon-median fold-change, the
inter-exon variance and the inter-exon coefficient of variance,
CV = variance/mean.
By sorting on the latter, differentially expressed genes with
high consistencies in the measured fold changes for each exon
can be found (that is, those that are changing but are unlikely
to be alternatively spliced between samples), and those where
the CV is high. This latter set has large variations in the fold
changes reported for each exon and can be considered to rep-
resent putative alternative splicing events. In list 4 there are
835 genes with CV higher than 0.5.
The exonmap package allows the structure of individual
genes to be plotted, and colored according to probeset
intensities or fold changes. Figures 3 and 4 show example
genes selected according to their inter-exon CV.
Identifying regions of novel transcription
Many probesets target regions of putative transcription, with
varying degrees of prior supporting evidence. By filtering the
DE probeset list (list 1) to retain intragenic probesets that do
not target known exons, or alternatively, to retain only inter-
genic probesets, novel regions of transcription can be
explored. There were 2,125 probesets identified that showed
above median expression in either the MCF7 or MCF10A data
(list 5). Of these, 1,170 were outside known genes (list 6) and
955 inside known genes but outside known exons (list 7). This
latter set was filtered as described above, with an additional
filter to remove probesets with low log fold change (<1). These
probesets have been translated into a list of genes suspected
to include putative or extended exons (list 8).
Examples of expression plots Figure 3
Examples of expression plots. Changes in differential expression between MCF7 and and MCF10A cell lines. Each plot represents a gene, and provides 
gene transcript and exon structure similar to that presented in the X:MAP web interface. Exon data are colored by mean fold-change between MCF7 and 
MCF10A, and scaled relative to the mean fold change for the entire gene. Only exon-targeting probesets uniquely hitting each gene are used for the 
calculations. Empty boxes with a cross through them represent exons that do not have a well behaved probeset targeting them with all probes.
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Detailed methods and an R script that produces all lists
described above are provided in Additional data file 2.
Discussion
The XMAP database and browser, and the exonmap R/Bio-
Conductor package, constitute a free and integrated solution
for the processing of Affymetrix exon arrays, starting from the
initial stages of whole experiment summarization and filter-
ing, through to fine-grained transcriptomic analyses of exon
expression and of splicing at the level of individual genes.
Visual representations of the complexity and diversity of
genome structure is challenging, and numerous solutions
have been presented (for example, [30-33]). Like the UCSC
[34] and Ensembl browsers, X:MAP provides access to tran-
script, exon and gene level information along with a web-
based mechanism to visualize it. While both the UCSC and
Ensembl browsers provide more types of annotation (includ-
ing contig and assembly information, and mappings between
transcripts and proteins), X:MAP itself focuses on exon array
annotation, and instead makes these data available via links
to other external resources (such as Ensembl). Affymetrix'
Integrated Genome Browser (IGB) provides these mappings
via a software application, but provides external links only to
the UCSC. In addition, X:MAP draws an explicit distinction
between probes and probesets that uniquely target the
genome in one place and those that match to more than one
location, something that is not done by other browsers,
although some of this information is made available (for the
previous generation of arrays) in NetAffx [35] and ADAPT
[14]. Another distinguishing feature of X:MAP is its novel use
of the Google Maps API [17] to provide a fully interactive real-
time scrolling interface to the underlying data, rather than
providing static pages rendered on the fly. This is particularly
advantageous when considering a set of adjacent genes that
do not fit into a single screen width.
Underpinning both the R package and browser is a relational
database storing genome hits for all the probes represented
Examples of expression graphs Figure 4
Examples of expression graphs. Line plots of individual probeset expression against genome location. All annotated exons are plotted along the x axis and 
colored as in Figure 3. These examples are taken from list 7 and represent genes containing intron-targeting probesets with significant behavior. The line 
plot includes these intronic probesets and allows their expression to be placed in the appropriate genomic context.
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on the array. The commercial software Genomatix' ChipIn-
spector adopts a similar approach, but uses single probes
combined with its own analysis methods, rather than depend-
ing on the standard probeset groupings defined by Affyme-
trix. A number of other commercial analysis tools for exon
arrays exist, such as Biotique System's XRAY, JMP® Microar-
ray, Partek® Genomics Suite, and Stratagene's ArrayAssist®.
Many of them are extensions of previously known software
products for standard arrays, and their major analytical aims
overlap with those available in exonmap and BioConductor/
R, that is, differential expression analysis and splicing analy-
sis. None of the commercial software suites allow integration
with the analytical libraries of R and all are proprietary and
licensed, while the X:MAP database and exonmap are free
and open source (available at [18,36], respectively).
Analysis of exon array data relies on a detailed understanding
of the relationship between genes, transcripts and exons and
their mappings to array probes/probesets. While genome-
structure data may also be processed using Ensembl front-
ends and APIs, such as EnsMart [20] or BioMart [21], they do
not provide the necessary mappings to exon array probes and
probesets. Basic information on cross-hybridization (under-
stood as multiple targeting to the genome) may be obtained
from NetAffx [35], but X:MAP handles more variants of
probeset characteristics. Thus, exonmap is the only package
providing access to fine-grained exon array annotation, and it
does so in BioConductor, a popular open source data analysis
environment. Exonmap allows probesets to be filtered by the
genome feature they are targeting so that, for example, only
probesets hitting known exons are retained, or to find
expressed probesets that hit the genome between known
genes or within known genes, but outside known exons.
Exonmap is unique in providing these data and, through
them, support for this sort of filtering. It is important because
genome annotation is incomplete [37] and changing [7]
because there is evidence of widespread transcription outside
known genes [8,9] and because feature density on these
arrays is very high, resulting in a relatively large number of
probes capable of hybridizing in more than one place. Many-
to-many relationships can be further refined at the exon level,
so that probesets that uniquely hit an exon, but with one or
more probes that might hybridize to other parts of the
genome, if expressed, can also be distinguished. This level of
selection is crucial particularly because the evidence support-
ing different probesets is variable, and should be reflected in
the amount of confidence ascribed to each one. X:MAP makes
it possible to focus selectively on high confidence, exon spe-
cific data or to widen the net to include less well characterized
probesets as appropriate for the analysis in hand.
Exonmap is designed to integrate exon array data with the
wide variety of data processing standards implemented in
BioConductor. BioConductor (and R) have a number of
advantages, which, through exonmap, can be exploited for
exon array data. Firstly, because they provide a programming
language based environment, it is possible to develop stand-
ard analysis workflows that can be applied successively to
multiple projects. Script-based analysis is particularly useful
when analyzing a number of different datasets over an
extended period of time, because analyses can be saved and
revisited at a later date. In an environment where multiple
collaborative projects are being worked on simultaneously,
this is important. The fact that R is a statistical programming
language means that it also provides access to a large number
of analytical techniques that can be applied to expression data
with little or no additional programming. This is particularly
useful when considering clinical datasets, where access to, for
example, Kaplan Meier or Cox models are required, as well as
a variety of clustering and classification tools. Additional
methods can also be developed as required. This latter point
is important; data analysis approaches are continuing to
evolve, and an open source environment, such as BioConduc-
tor that allows sharing and development of tools and
approaches can greatly facilitate these efforts.
Conclusion
Processing of exon arrays requires not only efficient handling
of genome annotations but also algorithmic flexibility,
combined with access to the right set of statistical techniques.
The first may be achieved using a properly designed database,
the latter with a programming language such as R, which pro-
vides access to a comprehensive toolbox of statistical
approaches and (through BioConductor) many state of the art
Histogram of number of probesets per exon Figure 5
Histogram of number of probesets per exon. Data are on a log10 scale. 
Most exons are targeted by a single probeset, but over 30% of them are 
targeted by more than one. Some exons are targeted by up to 34 
probesets.
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bioinformatics algorithms. Visualization techniques and data
presentation methods are also required.
By combining a fine-grained genome-level annotation data-
base (X:MAP), a genome browser and an R/BioConductor
package, the approach described here provides a unique solu-
tion to the problem of exon array analysis. Together, the soft-
ware tools allow a detailed representation of gene structure to
be used alongside the diversity of analytical techniques
offered by R and BioConductor in a single, open source, inte-
grated solution.
Additional data files
The following additional data are available with the online
version of this paper. Additional data file 1 is a description of
RNA preparation and the hybridization protocol. Additional
data file 2 is an R script to generate the lists of probesets and
genes described in the paper.
Additional data file 1 Description of RNA preparation and the hybridization protocol Description of RNA preparation and the hybridization protocol. Click here for file Additional data file 2 R script to generate the lists of probesets and genes described in the  paper R script to generate the lists of probesets and genes described in the  paper. Click here for file
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